Erlotinib (Tarceva) and Bevacizumab (Avastin): Combination Therapy for NSCLC

Ryan Smith, MD
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 14 de noviembre del 2003

Translation for this article does not exist

Blogs

The Power of a Cancer Support Group
by Bob Riter
May 26, 2016